B. Labeille

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

P. Joly, Maud Maho‐Vaillant, C. Prost‐Squarcioni et al. · The Lancet · 2017 · 596 citations

Medicine, Internal Medicine, Pharmacotherapy +9

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano et al. · Nature · 2011 · 522 citations

Medicine, Genetics, Oncology +14

Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial

Brigitte Dréno, Rainer Kunstfeld, Axel Hauschild et al. · The Lancet Oncology · 2017 · 206 citations

Medicine, Oncology, Pharmacology +12

Prediction of Survival for Patients With Bullous Pemphigoid

P. Joly, Jacques Bénichou, Catherine Lok et al. · Archives of Dermatology · 2005 · 164 citations

Medicine, Dermatology, Pharmacotherapy +14

Diagnosis of Adult Linear IgA Dermatosis by Immunoelectronmicroscopy in 16 Patients with Linear IgA Deposits

Catherine Prost, A Leça, P. Combemale et al. · Journal of Investigative Dermatology · 1989 · 110 citations

Medicine, Dermatology, Pathology +10